Erypeg 75mcg Injection
Images are for reference. Actual packaging may vary.
Prefilled of 0.3 ml • LiquidPrescription requiredSchedule H
Erypeg 75mcg Injection
Pegylated Recombinant Human Erythropoietin (75mcg)
₹7343.50
Prefilled of 0.3 ml • Liquid
A valid prescription is required for this medicine.
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Pegylated Recombinant Human Erythropoietin 75 mcg
How It Works
Pegylated Recombinant Human Erythropoietin binds to erythropoietin receptors in the bone marrow, stimulating erythropoiesis and increasing red blood cell production.
Medicine Strength
75 mcg
Uses & Benefits
Medical applications
Erypeg 75mcg Injection contains Pegylated Recombinant Human Erythropoietin, a long-acting erythropoiesis-stimulating agent used to treat anemia associated with chronic kidney disease (CKD), chemotherapy-induced anemia, and other conditions characterized by insufficient red blood cell production. The pegylation of erythropoietin prolongs its half-life, allowing for less frequent dosing compared to non-pegylated formulations.
Read full descriptionShow less
Erypeg stimulates erythroid progenitor cells in the bone marrow, promoting the synthesis of hemoglobin and increasing red blood cell count, thereby improving oxygen delivery to tissues. This injection is administered subcutaneously or intravenously under medical supervision, with dosage individualized based on patient response and hemoglobin levels. Monitoring of hemoglobin, hematocrit, and iron status is essential during therapy to optimize efficacy and minimize risks such as hypertension, thromboembolic events, and pure red cell aplasia.
Erypeg should be used cautiously in patients with uncontrolled hypertension or hypersensitivity to erythropoietin products. It is contraindicated in patients with hypersensitivity to any component of the formulation. Proper storage and handling are required to maintain product stability. Erypeg 75mcg Injection offers an effective therapeutic option for managing anemia, improving patient quality of life and reducing the need for blood transfusions.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side effects
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Safety Advice
Alcohol
Information regarding the use of Erypeg 75mcg Injection during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of Erypeg 75mcg Injection during breastfeeding is not available. Please consult your doctor.
Medical Advice
Driving
There is limited information available on the use of Erypeg 75mcg Injection in patients with kidney disease. Please consult your doctor.
Exercise Caution
Breastfeeding
It is not known whether Erypeg 75mcg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Kidney
There is limited information available on the use of Erypeg 75mcg Injection in patients with liver disease. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Erypeg 75mcg Injection
